メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
!!Link opens in a new tab
English
日本語
Keio Universityでコンテンツを検索
ホーム
プロファイル
研究部門
研究成果
Scopus著者プロファイル
松下 弘道
臨床検査医学
ウェブサイト
https://k-ris.keio.ac.jp/html/100016254_ja.html
h-index
1963
被引用数
23
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1988 …
2026
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(123)
類似のプロファイル
(6)
フィンガープリント
Hiromichi Matsushitaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Neoplasm
64%
Submandibular Gland
60%
Acute Promyelocytic Leukemia
60%
Immunoglobulin G4 Related Disease
45%
Disease
44%
Next Generation Sequencing
41%
Acute Myeloid Leukemia
37%
Diagnosis
36%
Leukemia Cell
33%
Leukemia
32%
Tyrosine-Kinase Inhibitor
30%
Prolymphocytic Leukemia
30%
Hematology
30%
Fusion Gene
30%
Lung Adenocarcinoma
30%
Platelet
30%
COVID-19 Vaccination
30%
Granulocyte
28%
Programmed Cell Death
28%
Retinoic Acid Receptor
24%
Fusion Protein
24%
Hematopoiesis
23%
Malignant Neoplasm
23%
Prospective Study
23%
Laboratory Test
22%
Minimal Residual Disease
22%
Molecularly Targeted Therapy
21%
Echography
19%
Chronic Myelogenous Leukemia
18%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Ribozyme
18%
Stomach Cancer
17%
Tretinoin
17%
Infection
17%
Acute Leukemia
17%
Event Free Survival
17%
Hematologic Malignancy
16%
Myelodysplastic Syndrome
16%
Treatment Response
16%
Metastatic Carcinoma
16%
In Vitro
15%
Ecotropic Viral Integration Site-1
15%
Anaplastic Large Cell Lymphoma
15%
Adipocyte
15%
Sulfhemoglobinemia
15%
Fatty Acid Oxidation
15%
Mantle Cell Lymphoma Cell
15%
Haemophilia A
15%
Emicizumab
15%
Transformed Cell
15%
Immunology and Microbiology
Myeloid
100%
Mouse
59%
Mycobacterium Avium Complex
45%
Granulocyte
42%
Leukemia Cell
36%
Severe Acute Respiratory Syndrome Coronavirus 2
30%
Submandibular Gland
30%
Immunoglobulin G4 Related Disease
30%
Minimum Inhibitory Concentration
30%
Platelet Count
30%
Downregulation
24%
Immunoglobulin G Antibody
23%
Fusion Gene
22%
Platelet
20%
COVID-19
20%
P-Glycoprotein
19%
Cell Proliferation
19%
Signal Transduction
18%
Virus Nucleocapsid
18%
Bcl-2
17%
Cell Line
17%
Immunoglobulin M Antibody
16%
Vaccine Efficacy
16%
Dynamics
15%
DNA Polymorphism
15%
Bone Marrow Transplantation
15%
Multidrug Resistance Protein 1
15%
Allogeneic Hematopoietic Stem Cell Transplantation
15%
Optics
15%
Hydrogen Peroxide
15%
Transformed Cell
15%
Idiopathic Thrombocytopenic Purpura
15%
CD14
15%
Induced Resistance
15%
Granulopoiesis
15%
Polymerase Chain Reaction
15%
Cell Death
15%
Promyelocytic Leukemia Protein
15%
Blood Cell Count
15%
Turbidity
15%
CCAAT Enhancer Binding Protein
15%
Humoral Immunity
15%
Screening
15%
Lateral Flow Assay
15%
Viral Disease
15%
Ascorbic Acid
15%
NKG2D
15%
Mycobacterium abscessus
15%
Adoptive Immunity
15%
Acute Promyelocytic Leukemia Cell Line
15%
Keyphrases
Leukemic Cells
81%
Concentrated Ascites Reinfusion Therapy
45%
Retinoic Acid Receptor
41%
Fusion Gene
33%
Acute Promyelocytic Leukemia
33%
Humanized
31%
T-cell Prolymphocytic Leukemia
30%
SEPT9-ABL1
30%
Ribozyme
30%
Cell-free
30%
AML1
30%
Clot Waveform Analysis
30%
Activated Partial Thromboplastin Time (aPTT)
30%
Bone Marrow
25%
Acute Myeloid Leukemia
23%
HL-60 Cells
22%
Retinoic Acid
21%
Chronic Myeloid Leukemia
20%
CD34+
18%
Fusion Transcript
18%
CD38
16%
Myelodysplastic Syndrome
16%
Overexpression
16%
Retinoid Resistance
16%
Acute Myeloid Leukemia Cells
16%
Immunodeficient Mice
16%
Ascites
16%
In Vivo Analysis
16%
Ecotropic Viral Integration site-1
15%
High Concentration
15%
Major Molecular Response
15%
Disease Kinetics
15%
Clinical Setting
15%
KPT-185
15%
Gene Aberrations
15%
FLT3 Internal Tandem Duplication
15%
Chylous
15%
Cytochrome P450 (CYP450)
15%
Myelomonocytic Cells
15%
P-glycoprotein (P-gp)
15%
Competitive PCR
15%
AML1-ETO
15%
Hemostasis Monitoring
15%
Emicizumab
15%
Hematology
15%
Monovalent Vaccine
15%
Chromosome 22
15%
Breast Cancer Invasion
15%
Hepatosplenic T-cell Lymphoma
15%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
15%
